カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の無菌注射剤用調剤医薬品市場予測2023-2029：モノクローナル抗体、インスリン、免疫グロブリン、サイトカイン、血液因子、その他

【英語タイトル】Sterile Injections Compounding Pharmacy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8684）・商品コード：MMG23LY8684
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：61
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の無菌注射剤用調剤医薬品市場規模と予測を収録しています。・世界の無菌注射剤用調剤医薬品市場：売上、2018年-2023年、2024年-2029年
・世界の無菌注射剤用調剤医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の無菌注射剤用調剤医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル抗体」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

無菌注射剤用調剤医薬品のグローバル主要企業は、Johnson & Johnson Merck & Co.、 GlaxoSmithKline、 Gilead Sciences、 Baxter International、 Amgen、 Novartis AG、 Sanofi、 Pfizer、 Novo Nordisk A/S、 Merck & Co.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、無菌注射剤用調剤医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の無菌注射剤用調剤医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界の無菌注射剤用調剤医薬品市場：タイプ別市場シェア、2022年
・モノクローナル抗体、インスリン、免疫グロブリン、サイトカイン、血液因子、その他

世界の無菌注射剤用調剤医薬品市場：用途別、2018年-2023年、2024年-2029年
世界の無菌注射剤用調剤医薬品市場：用途別市場シェア、2022年
・18歳以下消費者、19歳ｰ44歳消費者、45歳ｰ64歳消費者、65歳以上消費者

世界の無菌注射剤用調剤医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界の無菌注射剤用調剤医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における無菌注射剤用調剤医薬品のグローバル売上、2018年-2023年
・主要企業における無菌注射剤用調剤医薬品のグローバル売上シェア、2022年
・主要企業における無菌注射剤用調剤医薬品のグローバル販売量、2018年-2023年
・主要企業における無菌注射剤用調剤医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson & Johnson Merck & Co.、 GlaxoSmithKline、 Gilead Sciences、 Baxter International、 Amgen、 Novartis AG、 Sanofi、 Pfizer、 Novo Nordisk A/S、 Merck & Co.

*************************************************************

・調査・分析レポートの概要
無菌注射剤用調剤医薬品市場の定義
市場セグメント
世界の無菌注射剤用調剤医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の無菌注射剤用調剤医薬品市場規模
世界の無菌注射剤用調剤医薬品市場規模：2022年 VS 2029年
世界の無菌注射剤用調剤医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの無菌注射剤用調剤医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の無菌注射剤用調剤医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル抗体、インスリン、免疫グロブリン、サイトカイン、血液因子、その他
無菌注射剤用調剤医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：18歳以下消費者、19歳ｰ44歳消費者、45歳ｰ64歳消費者、65歳以上消費者
無菌注射剤用調剤医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別無菌注射剤用調剤医薬品市場規模 2022年と2029年
地域別無菌注射剤用調剤医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson Merck & Co.、 GlaxoSmithKline、 Gilead Sciences、 Baxter International、 Amgen、 Novartis AG、 Sanofi、 Pfizer、 Novo Nordisk A/S、 Merck & Co.
...

Sterile Injections Compounding Pharmacy can be applied in the standard way (i.e. intravenously) or subcutaneous and intramuscular
This report aims to provide a comprehensive presentation of the global market for Sterile Injections Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Injections Compounding Pharmacy. This report contains market size and forecasts of Sterile Injections Compounding Pharmacy in global, including the following market information:
Global Sterile Injections Compounding Pharmacy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Sterile Injections Compounding Pharmacy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sterile Injections Compounding Pharmacy include Johnson & Johnson Merck & Co., GlaxoSmithKline, Gilead Sciences, Baxter International, Amgen, Novartis AG, Sanofi, Pfizer and Novo Nordisk A/S, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sterile Injections Compounding Pharmacy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sterile Injections Compounding Pharmacy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Sterile Injections Compounding Pharmacy Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Insulin
Immunoglobulin
Cytokines
Blood Factors
Others
Global Sterile Injections Compounding Pharmacy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Sterile Injections Compounding Pharmacy Market Segment Percentages, by Application, 2022 (%)
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
Global Sterile Injections Compounding Pharmacy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Sterile Injections Compounding Pharmacy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sterile Injections Compounding Pharmacy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Sterile Injections Compounding Pharmacy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson Merck & Co.
GlaxoSmithKline
Gilead Sciences
Baxter International
Amgen
Novartis AG
Sanofi
Pfizer
Novo Nordisk A/S
Merck & Co.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sterile Injections Compounding Pharmacy, market overview.
Chapter 2: Global Sterile Injections Compounding Pharmacy market size in revenue.
Chapter 3: Detailed analysis of Sterile Injections Compounding Pharmacy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sterile Injections Compounding Pharmacy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Sterile Injections Compounding Pharmacy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sterile Injections Compounding Pharmacy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sterile Injections Compounding Pharmacy Overall Market Size
2.1 Global Sterile Injections Compounding Pharmacy Market Size: 2022 VS 2029
2.2 Global Sterile Injections Compounding Pharmacy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sterile Injections Compounding Pharmacy Players in Global Market
3.2 Top Global Sterile Injections Compounding Pharmacy Companies Ranked by Revenue
3.3 Global Sterile Injections Compounding Pharmacy Revenue by Companies
3.4 Top 3 and Top 5 Sterile Injections Compounding Pharmacy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Sterile Injections Compounding Pharmacy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sterile Injections Compounding Pharmacy Players in Global Market
3.6.1 List of Global Tier 1 Sterile Injections Compounding Pharmacy Companies
3.6.2 List of Global Tier 2 and Tier 3 Sterile Injections Compounding Pharmacy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Sterile Injections Compounding Pharmacy Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Insulin
4.1.4 Immunoglobulin
4.1.5 Cytokines
4.1.6 Blood Factors
4.1.7 Others
4.2 By Type – Global Sterile Injections Compounding Pharmacy Revenue & Forecasts
4.2.1 By Type – Global Sterile Injections Compounding Pharmacy Revenue, 2018-2023
4.2.2 By Type – Global Sterile Injections Compounding Pharmacy Revenue, 2024-2029
4.2.3 By Type – Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sterile Injections Compounding Pharmacy Market Size, 2022 & 2029
5.1.2 Consumers Aged 18 and Younger
5.1.3 Consumers Aged 19 to 44
5.1.4 Consumers Aged 45 to 64
5.1.5 Consumers Aged 65 and Older
5.2 By Application – Global Sterile Injections Compounding Pharmacy Revenue & Forecasts
5.2.1 By Application – Global Sterile Injections Compounding Pharmacy Revenue, 2018-2023
5.2.2 By Application – Global Sterile Injections Compounding Pharmacy Revenue, 2024-2029
5.2.3 By Application – Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Sterile Injections Compounding Pharmacy Market Size, 2022 & 2029
6.2 By Region – Global Sterile Injections Compounding Pharmacy Revenue & Forecasts
6.2.1 By Region – Global Sterile Injections Compounding Pharmacy Revenue, 2018-2023
6.2.2 By Region – Global Sterile Injections Compounding Pharmacy Revenue, 2024-2029
6.2.3 By Region – Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Sterile Injections Compounding Pharmacy Revenue, 2018-2029
6.3.2 US Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.3.3 Canada Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.3.4 Mexico Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Sterile Injections Compounding Pharmacy Revenue, 2018-2029
6.4.2 Germany Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.4.3 France Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.4.4 U.K. Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.4.5 Italy Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.4.6 Russia Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.4.7 Nordic Countries Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.4.8 Benelux Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Sterile Injections Compounding Pharmacy Revenue, 2018-2029
6.5.2 China Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.5.3 Japan Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.5.4 South Korea Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.5.5 Southeast Asia Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.5.6 India Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Sterile Injections Compounding Pharmacy Revenue, 2018-2029
6.6.2 Brazil Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.6.3 Argentina Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Sterile Injections Compounding Pharmacy Revenue, 2018-2029
6.7.2 Turkey Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.7.3 Israel Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.7.4 Saudi Arabia Sterile Injections Compounding Pharmacy Market Size, 2018-2029
6.7.5 UAE Sterile Injections Compounding Pharmacy Market Size, 2018-2029
7 Sterile Injections Compounding Pharmacy Companies Profiles
7.1 Johnson & Johnson Merck & Co.
7.1.1 Johnson & Johnson Merck & Co. Company Summary
7.1.2 Johnson & Johnson Merck & Co. Business Overview
7.1.3 Johnson & Johnson Merck & Co. Sterile Injections Compounding Pharmacy Major Product Offerings
7.1.4 Johnson & Johnson Merck & Co. Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Merck & Co. Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Sterile Injections Compounding Pharmacy Major Product Offerings
7.2.4 GlaxoSmithKline Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Sterile Injections Compounding Pharmacy Major Product Offerings
7.3.4 Gilead Sciences Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Baxter International
7.4.1 Baxter International Company Summary
7.4.2 Baxter International Business Overview
7.4.3 Baxter International Sterile Injections Compounding Pharmacy Major Product Offerings
7.4.4 Baxter International Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.4.5 Baxter International Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Sterile Injections Compounding Pharmacy Major Product Offerings
7.5.4 Amgen Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Sterile Injections Compounding Pharmacy Major Product Offerings
7.6.4 Novartis AG Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Sterile Injections Compounding Pharmacy Major Product Offerings
7.7.4 Sanofi Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Sterile Injections Compounding Pharmacy Major Product Offerings
7.8.4 Pfizer Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Novo Nordisk A/S
7.9.1 Novo Nordisk A/S Company Summary
7.9.2 Novo Nordisk A/S Business Overview
7.9.3 Novo Nordisk A/S Sterile Injections Compounding Pharmacy Major Product Offerings
7.9.4 Novo Nordisk A/S Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.9.5 Novo Nordisk A/S Key News & Latest Developments
7.10 Merck & Co.
7.10.1 Merck & Co. Company Summary
7.10.2 Merck & Co. Business Overview
7.10.3 Merck & Co. Sterile Injections Compounding Pharmacy Major Product Offerings
7.10.4 Merck & Co. Sterile Injections Compounding Pharmacy Revenue in Global Market (2018-2023)
7.10.5 Merck & Co. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Sterile Injections Compounding Pharmacy Market Opportunities & Trends in Global Market
Table 2. Sterile Injections Compounding Pharmacy Market Drivers in Global Market
Table 3. Sterile Injections Compounding Pharmacy Market Restraints in Global Market
Table 4. Key Players of Sterile Injections Compounding Pharmacy in Global Market
Table 5. Top Sterile Injections Compounding Pharmacy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Sterile Injections Compounding Pharmacy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Sterile Injections Compounding Pharmacy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Sterile Injections Compounding Pharmacy Product Type
Table 9. List of Global Tier 1 Sterile Injections Compounding Pharmacy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sterile Injections Compounding Pharmacy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Sterile Injections Compounding Pharmacy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Sterile Injections Compounding Pharmacy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Sterile Injections Compounding Pharmacy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Sterile Injections Compounding Pharmacy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Sterile Injections Compounding Pharmacy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Sterile Injections Compounding Pharmacy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2024-2029
Table 30. Johnson & Johnson Merck & Co. Company Summary
Table 31. Johnson & Johnson Merck & Co. Sterile Injections Compounding Pharmacy Product Offerings
Table 32. Johnson & Johnson Merck & Co. Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Merck & Co. Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Sterile Injections Compounding Pharmacy Product Offerings
Table 36. GlaxoSmithKline Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Gilead Sciences Company Summary
Table 39. Gilead Sciences Sterile Injections Compounding Pharmacy Product Offerings
Table 40. Gilead Sciences Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 41. Gilead Sciences Key News & Latest Developments
Table 42. Baxter International Company Summary
Table 43. Baxter International Sterile Injections Compounding Pharmacy Product Offerings
Table 44. Baxter International Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 45. Baxter International Key News & Latest Developments
Table 46. Amgen Company Summary
Table 47. Amgen Sterile Injections Compounding Pharmacy Product Offerings
Table 48. Amgen Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Sterile Injections Compounding Pharmacy Product Offerings
Table 52. Novartis AG Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis AG Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Sterile Injections Compounding Pharmacy Product Offerings
Table 56. Sanofi Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Sterile Injections Compounding Pharmacy Product Offerings
Table 60. Pfizer Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Novo Nordisk A/S Company Summary
Table 63. Novo Nordisk A/S Sterile Injections Compounding Pharmacy Product Offerings
Table 64. Novo Nordisk A/S Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 65. Novo Nordisk A/S Key News & Latest Developments
Table 66. Merck & Co. Company Summary
Table 67. Merck & Co. Sterile Injections Compounding Pharmacy Product Offerings
Table 68. Merck & Co. Sterile Injections Compounding Pharmacy Revenue (US$, Mn) & (2018-2023)
Table 69. Merck & Co. Key News & Latest Developments
List of Figures
Figure 1. Sterile Injections Compounding Pharmacy Segment by Type in 2022
Figure 2. Sterile Injections Compounding Pharmacy Segment by Application in 2022
Figure 3. Global Sterile Injections Compounding Pharmacy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sterile Injections Compounding Pharmacy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Sterile Injections Compounding Pharmacy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sterile Injections Compounding Pharmacy Revenue in 2022
Figure 8. By Type - Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 16. US Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 20. Germany Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 21. France Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 28. China Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 32. India Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 34. Brazil Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Sterile Injections Compounding Pharmacy Revenue Market Share, 2018-2029
Figure 37. Turkey Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Sterile Injections Compounding Pharmacy Revenue, (US$, Mn), 2018-2029
Figure 41. Johnson & Johnson Merck & Co. Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Gilead Sciences Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Baxter International Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amgen Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis AG Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novo Nordisk A/S Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck & Co. Sterile Injections Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の無菌注射剤用調剤医薬品市場予測2023-2029：モノクローナル抗体、インスリン、免疫グロブリン、サイトカイン、血液因子、その他] (コード：MMG23LY8684)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の無菌注射剤用調剤医薬品市場予測2023-2029：モノクローナル抗体、インスリン、免疫グロブリン、サイトカイン、血液因子、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の免疫学的製剤市場予測2023-2029：抗リウマチ薬（DMARD）、免疫グロブリン、免疫調節剤、免疫抑制剤、モノクローナル抗体、その他
  • 世界の原発性免疫不全薬市場予測2023-2029：サイトカイン、抗サイトカイン抗体、シグナル分子阻害剤
  • 世界のタンパク質阻害剤市場予測2023-2029：プロテインキナーゼ阻害剤、モノクローナル抗体、その他
  • 世界のヒト血漿分画市場予測2023-2029：免疫グロブリン、凝固因子、アルブミン、その他
  • 世界の血漿タンパク質製品市場予測2023-2029：アルブミン、免疫グロブリン、凝固因子、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆